title: [Thymogen in the complex treatment of inflammatory diseases of the female genital system].
abstract: Thymogen, a new immunomodulating drug made in this country, was used in combined therapy of 46 patients with acute endomyometritis, exacerbations of chronic salpingo-oophoritis, purulent tubo-ovarian formations. Thymogen therapy was conducive to normalization of lymphocyte counts, absolute counts of T and B lymphocytes, increase of T lymphocyte functional activity. The drug is characterized by a desensitizing effect and induces no complications. Marked clinical effect recommends the immunomodulator thymogen for combined therapy of patients with inflammatory diseases of the uterus and its appendages.
authors: Iu V
authors: IuV
authors: Tsvelev
authors: V Kh
authors: VKh
authors: Khavinson
authors: A V
authors: AV
authors: Diachuk
authors: A V
authors: AV
authors: Gur'ev
authors: S V
authors: SV
authors: Seryĭ
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D002908:Chronic Disease; D004151:Dipeptides; D004359:Drug Therapy, Combination; D004716:Endometritis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D005260:Female; D006801:Humans; D008231:Lymphopenia / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D010455:Peptides / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D004151:Dipeptides; D010455:Peptides; C060736:thymogen
vernacular_title: Timogen v kompleksnom lechenii vospalitel'nykh zabolevaniĭ zhenskoĭ polovoĭ sistemy.